Daniel Miller, DO
Vascular Surgery · Chandler, AZNPI 1972747376
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 58.4% of the total. Reporting peaked in 2022 at $2,862 and has fallen 76.2% since, to $682 in 2025.
Across 107 payments — averaging $78.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- W. L. Gore & Associates, Inc.$3K
- Silk Road Medical, Inc.$277
- Endologix LLC$200
- Bard Peripheral Vascular, Inc.$130
- Abiomed$95
- plus $209 from 5 others
What the payments were for
- Consulting fees$1,05013%
- Speaking & faculty fees$3,08837%
- Travel & lodging$1,09713%
- Food & beverage$3,15938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 39 | $4,904 |
| W. L. Gore & Associates, Inc. | 52 | $2,579 |
| Silk Road Medical, Inc. | 6 | $277 |
| Endologix LLC | 1 | $200 |
| Bard Peripheral Vascular, Inc. | 1 | $130 |
| Abiomed | 1 | $95 |
| Bolton Medical Inc | 3 | $82 |
| Terumo Medical Corporation | 1 | $75 |
| BD | 1 | $22 |
| Getinge USA Sales, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$2,600
- Endurant$1,702
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,097
- Alto Abdominal Stent Graft System$200
- ENROUTE Transcarotid Neuroprotection System$174
- ENROUTE Transcarotid Stent$174
- GORE TAG Conformable Thoracic Endoprosthesis$151
- Concerto-NV$137
- LIFESTREAM$130
- Conformable TAG Thoracic Endoprosthesis$125
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$121
- VIABAHN VBX Balloon Expandable Endoprosthesis$116
- EXCLUDER AAA Endoprosthesis$103
How this compares
$8,394 in reported general payments places this provider in the 55th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 43 | $54,785 |
| ClopidogrelClopidogrel Bisulfate | 185 | $2,275 |
| SsdSilver Sulfadiazine | 11 | $374 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 18 | $217 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $133 |
| Doxycycline Monohydrate | 13 | $98 |
| Ibuprofen | 20 | $44 |
| Alprazolam | 21 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $12 | $54,78543 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Chandler
- Joseph VijungcoChandler$63K
- Albert HarrisonChandler$52K
- Brett SiegristChandler$8K
- Venkatesh RamaiahScottsdale$452K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Hammad AmerMesa$169K
- Baljeet UppalSun City$166K
- Scott BermanTuscon$150K
- Martin ZomayaPhoenix$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.